Genetics of Atropine for Myopia control in childrE

Recruiting

• Conditions: H52.1; Myopia

• Registration Number: DRKS00030053
• Lead Sponsor: niversitätsklinik Freiburg, Klinik für Augenheilkunde

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Participation in the AIM study, written informed consent obtained from the patient and his/her parents/legal guardians

Exclusion Criteria

No written informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Correlating a myopia risk score with the efficacy of low-dose atropine therapy

Secondary Outcome Measures

Name	Time	Method
Correlating other myopia and atropine related polymorphisms with the efficacy of low-dose atropine therapy